Jefferies analyst David Windley upgraded Oscar Health (OSCR) to Hold from Underperform with a price target of $16, up from $10. The firm says data and industry checks point to healthcare exchange enrollment trending favorably versus expectations. Oscar is likely increasing its market share of “good risk,” the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSCR: